Michael Caligiuri

Department of Psychiatry, University of California, San Diego

Affiliated withUniversity of California, San Diego

Research Area

Biography

Michael Caligiuri has not added Biography.
If you are Michael Caligiuri and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 34	2013

Other Publications

Article	Year
The role of STAT1 in viral sensitization to LPS. Journal of endotoxin research\| PubMed ID: 14577848	2003
BAALC, a novel marker of human hematopoietic progenitor cells. Experimental hematology\| PubMed ID: 14585369	2003
A quantitative neuromotor predictor of antidepressant non-response in patients with major depression. Journal of affective disorders\| PubMed ID: 14607390	2003
A pilot study of high-throughput, sequence-based mutational profiling of primary human acute myeloid leukemia cell genomes. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 14614138	2003
Rituximab: converging mechanisms of action in non-Hodgkin's lymphoma? Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 14676100	2003
EBV kidney allograft infection: possible relationship with a peri-graft localization of PTLD. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons\| PubMed ID: 14678042	2004
NK cell and DC interactions. Trends in immunology\| PubMed ID: 14698284	2004
Loss of C/EBP alpha and favorable prognosis of acute myeloid leukemias: a biological paradox. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 14726508	2004
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia. Lancet\| PubMed ID: 14975618	2004
Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 15007164	2004
Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells. Blood\| PubMed ID: 15016654	2004
A functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder. Bipolar disorders\| PubMed ID: 15117397	2004
Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements? Journal of clinical psychopharmacology\| PubMed ID: 15118484	2004
Association of diabetes with dyskinesia in older psychosis patients. Psychopharmacology\| PubMed ID: 15138754	2004
AIDS-associated malignancies. Cancer chemotherapy and biological response modifiers\| PubMed ID: 15338771	2003
Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease. Blood\| PubMed ID: 15374888	2005
Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15447996	2004
Cytokine modulation of the innate immune system in the treatment of leukemia and lymphoma. Advances in pharmacology (San Diego, Calif.)\| PubMed ID: 15464915	2004
Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder. Journal of the National Cancer Institute\| PubMed ID: 15467034	2004
A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. Genomics\| PubMed ID: 15475242	2004
Anti-human CTLA-4 monoclonal antibody promotes T-cell expansion and immunity in a hu-PBL-SCID model: a new method for preclinical screening of costimulatory monoclonal antibodies. Blood\| PubMed ID: 15486062	2005
IFN-gamma gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice. Blood\| PubMed ID: 15498860	2005
Functional brain asymmetries during visuomotor tracking. Journal of clinical and experimental neuropsychology\| PubMed ID: 15512926	2004
Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than ... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 15514371	2004
Failed adoptive immunotherapy with tumor-specific T cells: reversal with low-dose interleukin 15 but not low-dose interleukin 2. Cancer research\| PubMed ID: 15520217	2004
Immunotherapeutic approaches for hematologic malignancies. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program\| PubMed ID: 15561691	2004
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation. Blood\| PubMed ID: 15604218	2005
Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss-of-function mutations. Genes, chromosomes & cancer\| PubMed ID: 15645492	2005
Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector. Journal of immunological methods\| PubMed ID: 15680156	2005
Interleukin-2, interleukin-15, and their roles in human natural killer cells. Advances in immunology\| PubMed ID: 15705423	2005
Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia. Nature genetics\| PubMed ID: 15723065	2005
The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood\| PubMed ID: 15774615	2005
A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity\| PubMed ID: 15780987	2005
Relationship of neuromotor disturbances to psychosis symptoms in first-episode neuroleptic-naive schizophrenia patients. Schizophrenia research\| PubMed ID: 15820325	2005
Cellular uptake and intracellular levels of the bcl-2 antisense g3139 in cultured cells and treated patients with acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 15837754	2005
IL-15 but not IL-2 rapidly induces lethal xenogeneic graft-versus-host disease. Blood\| PubMed ID: 15976176	2005
Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti-CTLA-4 antibodies. Blood\| PubMed ID: 16037385	2005
Durable hematologic complete response and suppression of HTLV-1 viral load following alemtuzumab in zidovudine/IFN-{alpha}-refractory adult T-cell leukemia. Blood\| PubMed ID: 16076875	2005
Do preclinical findings of methamphetamine-induced motor abnormalities translate to an observable clinical phenotype? Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology\| PubMed ID: 16123755	2005
Lateralized cognitive dysfunction and psychotic symptoms in schizophrenia. Schizophrenia research\| PubMed ID: 16125374	2005
The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene. Molecular and cellular biology\| PubMed ID: 16135788	2005
Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12. Cancer research\| PubMed ID: 16204085	2005
Cytokine therapy for cancer: antigen presentation. Cancer treatment and research\| PubMed ID: 16211874	2005
Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16275934	2005
The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein. Cancer cell\| PubMed ID: 16286244	2005
A MAPK/HNRPK pathway controls BCR/ABL oncogenic potential by regulating MYC mRNA translation. Blood\| PubMed ID: 16293596	2006
EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated disease. Virology\| PubMed ID: 16321417	2006
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted ther... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16344317	2006
Human natural killer cell development and biology. Blood reviews\| PubMed ID: 16364519	2006
Responsiveness of naive CD4 T cells to polarizing cytokine determines the ratio of Th1 and Th2 cell differentiation. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 16424184	2006
Pharmacogenetics for off-patent antipsychotics: reframing the risk for tardive dyskinesia and access to essential medicines. Expert opinion on pharmacotherapy\| PubMed ID: 16433578	2006
STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo. European journal of immunology\| PubMed ID: 16482512	2006
Striatopallidal regulation of affect in bipolar disorder. Journal of affective disorders\| PubMed ID: 16503055	2006
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network : JNCCN\| PubMed ID: 16507273	2006
Autologous immune strategies to reduce the risk of leukemic relapse: consideration for IL-15. Best practice & research. Clinical haematology\| PubMed ID: 16516125	2006
FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways. Blood\| PubMed ID: 16543474	2006
Tumor growth impedes natural-killer-cell maturation in the bone marrow. Blood\| PubMed ID: 16556890	2006
Recent advances in the treatment of transplant-related lymphoma. Clinical advances in hematology & oncology : H&O\| PubMed ID: 16562366	2006
Evidence for discrete stages of human natural killer cell differentiation in vivo. The Journal of experimental medicine\| PubMed ID: 16606675	2006
Immunologic approaches to acute leukemia in the elderly. Seminars in hematology\| PubMed ID: 16616045	2006
Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16622259	2006
Quantitative measurement of handwriting in the assessment of drug-induced parkinsonism. Human movement science\| PubMed ID: 16647772	2006
Independent confirmation of a prognostic gene-expression signature in adult acute myeloid leukemia with a normal karyotype: a Cancer and Leukemia Group B study. Blood\| PubMed ID: 16670265	2006
Pro- and antiinflammatory cytokine signaling: reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity\| PubMed ID: 16713975	2006
Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16740775	2006
Cancer and leukemia group B leukemia correlative science committee: major accomplishments and future directions. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16740786	2006
Trans-presentation of donor-derived interleukin 15 is necessary for the rapid onset of acute graft-versus-host disease but not for graft-versus-tumor activity. Blood\| PubMed ID: 16757683	2006
A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 16818697	2006
Impaired hemispheric communication in schizophrenia: a study using the consonant-vowel-consonant task. Schizophrenia research\| PubMed ID: 16822652	2006
PhenoChipping of psychotic disorders: a novel approach for deconstructing and quantitating psychiatric phenotypes. American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics\| PubMed ID: 16838358	2006
The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European bloo... Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation\| PubMed ID: 16864058	2006
Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and p... Blood\| PubMed ID: 16902153	2006
Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 16908838	2006
Abnormalities in motor physiology in bipolar disorder. The Journal of neuropsychiatry and clinical neurosciences\| PubMed ID: 16963583	2006
Mll partial tandem duplication induces aberrant Hox expression in vivo via specific epigenetic alterations. The Journal of clinical investigation\| PubMed ID: 16981007	2006
Human natural killer cell development. Immunological reviews\| PubMed ID: 17100876	2006
Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells. Blood\| PubMed ID: 17110450	2007
Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions. Journal of clinical psychopharmacology\| PubMed ID: 17110811	2006
A phase 2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17145827	2006
Long-term disease-free survivors with cytogenetically normal acute myeloid leukemia and MLL partial tandem duplication: a Cancer and Leukemia Group B study. Blood\| PubMed ID: 17341662	2007
Internal versus external: oral-motor performance as a function of attentional focus. Journal of speech, language, and hearing research : JSLHR\| PubMed ID: 17344554	2007
Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17404098	2007
Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical. Blood\| PubMed ID: 17440052	2007
High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2 dependent suppression of C/EBPalpha-driven myeloid differentiation. Blood\| PubMed ID: 17475908	2007
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia. Blood\| PubMed ID: 17475912	2007
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood\| PubMed ID: 17494858	2007
Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia. Blood\| PubMed ID: 17537993	2007
Chronic lymphocytosis of functionally immature natural killer cells. The Journal of allergy and clinical immunology\| PubMed ID: 17604094	2007
Transcriptional control of human T-BET expression: the role of Sp1. European journal of immunology\| PubMed ID: 17705132	2007
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. The Journal of clinical investigation\| PubMed ID: 17717597	2007
The PP2A inhibitor SET regulates natural killer cell IFN-gamma production. The Journal of experimental medicine\| PubMed ID: 17875674	2007
Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 17881568	2007
Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis. Blood\| PubMed ID: 17925491	2008
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukem... Blood\| PubMed ID: 17940205	2008
SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients. Genes, chromosomes & cancer\| PubMed ID: 18064648	2008
Bortezomib induces DNA hypomethylation and silenced gene transcription by interfering with Sp1/NF-kappaB-dependent DNA methyltransferase activity in acute myeloid leukemia. Blood\| PubMed ID: 18083845	2008
Colocalization of the IL-12 receptor and FcgammaRIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-gamma. Blood\| PubMed ID: 18174382	2008
IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cell... Blood\| PubMed ID: 18182577	2008
Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. Journal of clinical psychopharmacology\| PubMed ID: 18204344	2008
A novel Raji-Burkitt's lymphoma model for preclinical and mechanistic evaluation of CD52-targeted immunotherapeutic agents. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 18223233	2008
Isolation and characterization of human natural killer cell subsets. Current protocols in immunology / edited by John E. Coligan ... [et al.]\| PubMed ID: 18432933	2004
MicroRNA expression in cytogenetically normal acute myeloid leukemia. The New England journal of medicine\| PubMed ID: 18450603	2008
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18559874	2008
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication. Blood\| PubMed ID: 18566324	2008
Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 97... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18591543	2008
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele. Blood\| PubMed ID: 18617636	2008
Human natural killer cells. Blood\| PubMed ID: 18650461	2008
TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 18768831	2008
Natural killer cells in innate immunity and cancer. Journal of immunotherapy (Hagerstown, Md. : 1997)\| PubMed ID: 18779751	2008
Tumor growth decreases NK and B cells as well as common lymphoid progenitor. PloS one\| PubMed ID: 18784839	2008
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 18809607	2008
The Axl/Gas6 pathway is required for optimal cytokine signaling during human natural killer cell development. Blood\| PubMed ID: 18840707	2009
A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab. Breast cancer research and treatment\| PubMed ID: 19051009	2009
Stem cell factor and interleukin-2/15 combine to enhance MAPK-mediated proliferation of human natural killer cells. Blood\| PubMed ID: 19060242	2009
The humanized CD40 antibody SGN-40 demonstrates pre-clinical activity that is enhanced by lenalidomide in chronic lymphocytic leukaemia. British journal of haematology\| PubMed ID: 19183192	2009
Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22. Blood\| PubMed ID: 19244159	2009
TSC-22 contributes to hematopoietic precursor cell proliferation and repopulation and is epigenetically silenced in large granular lymphocyte leukemia. Blood\| PubMed ID: 19329776	2009
Reformed consent: adapting to new media and research participant preferences. IRB\| PubMed ID: 19402337	2009
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer a... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19451432	2009
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells. Blood\| PubMed ID: 19553639	2009
A novel mouse model for the aggressive variant of NK cell and T cell large granular lymphocyte leukemia. Leukemia research\| PubMed ID: 19660811	2010
Handwriting movement analyses for monitoring drug-induced motor side effects in schizophrenia patients treated with risperidone. Human movement science\| PubMed ID: 19692133	2009
CD94 defines phenotypically and functionally distinct mouse NK cell subsets. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19801519	2009
CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets. Blood\| PubMed ID: 19897577	2010
CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody. Blood\| PubMed ID: 19965644	2010
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer a... Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20026798	2010
Purification of human NK cell developmental intermediates from lymph nodes and tonsils. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 20033630	2010
Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity ... mAbs\| PubMed ID: 20081380	2010
In vivo role of Flt3 ligand and dendritic cells in NK cell homeostasis. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 20142363	2010
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell\| PubMed ID: 20211135	2010
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 20368543	2010
Handwriting movement kinematics for quantifying extrapyramidal side effects in patients treated with atypical antipsychotics. Psychiatry research\| PubMed ID: 20381875	2010
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer cell\| PubMed ID: 20385359	2010
Mutations of the Wilms tumor 1 gene (WT1) in older patients with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Blood\| PubMed ID: 20442368	2010
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody. Blood\| PubMed ID: 20460501	2010
Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity\| PubMed ID: 20620944	2010
FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute m... Blood\| PubMed ID: 20656931	2010
Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 20802153	2010
BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a... Blood\| PubMed ID: 20841507	2010
PRDM1/Blimp-1 controls effector cytokine production in human NK cells. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 20944005	2010
The dynamic character of disguise behavior for text-based, mixed, and stylized signatures. Journal of forensic sciences\| PubMed ID: 20950317	2011
Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21079133	2010
The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells. Blood\| PubMed ID: 21156847	2011
Innate or adaptive immunity? The example of natural killer cells. Science (New York, N.Y.)\| PubMed ID: 21212348	2011
IÎºBÎ¶ augments IL-12- and IL-18-mediated IFN-Î³ production in human NK cells. Blood\| PubMed ID: 21224476	2011
A sheep in wolf's clothing. Blood\| PubMed ID: 21292781	2011
TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21343549	2011
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human. The Journal of clinical investigation\| PubMed ID: 21364281	2011
The large zinc finger protein ZAS3 is a critical modulator of osteoclastogenesis. PloS one\| PubMed ID: 21390242	2011
Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid... Haematologica\| PubMed ID: 21659357	2011
LyGDI, a novel SHIP-interacting protein, is a negative regulator of FcγR-mediated phagocytosis. PloS one\| PubMed ID: 21695085	2011
Associations between spontaneous movement abnormalities and psychotic-like experiences in the general population. Schizophrenia research\| PubMed ID: 21782390	2011
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia. Blood\| PubMed ID: 21828125	2011
Voxel-based morphometry of patients with schizophrenia or bipolar I disorder: a matched control study. Psychiatry research\| PubMed ID: 21924872	2011
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect. Blood\| PubMed ID: 22031859	2011
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category. Blood\| PubMed ID: 22031865	2011
Targeted immunotherapy for acute myeloid leukemia. Best practice & research. Clinical haematology\| PubMed ID: 22127317	2011
Up-regulation of a HOXA-PBX3 homeobox-gene signature following down-regulation of miR-181 is associated with adverse prognosis in patients with cytogenetically abnormal AML. Blood\| PubMed ID: 22251480	2012
Extracellular matrix protein CCN1 limits oncolytic efficacy in glioma. Cancer research\| PubMed ID: 22282654	2012
Age-related prognostic impact of different types of DNMT3A mutations in adults with primary cytogenetically normal acute myeloid leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 22291079	2012
Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer Cells. Advances in virology\| PubMed ID: 22312364	2012
The HDAC inhibitor valproic acid lessens NK cell action against oncolytic virus-infected glioblastoma cells with inhibition of STAT5/T-BET signaling and IFNÎ³ generation. Journal of virology\| PubMed ID: 22318143	2012
Evidence for a stepwise program of extrathymic T cell development within the human tonsil. The Journal of clinical investigation\| PubMed ID: 22378041	2012
MiR-155 regulates IFN-Î³ production in natural killer cells. Blood\| PubMed ID: 22378844	2012
Regulation of acute graft-versus-host disease by microRNA-155. Blood\| PubMed ID: 22408260	2012
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia. Blood\| PubMed ID: 22529287	2012
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia. Blood\| PubMed ID: 22566605	2012
Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias. Blood\| PubMed ID: 22674806	2012
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia. Blood\| PubMed ID: 22677130	2012
Stress hematopoiesis reveals abnormal control of self-renewal, lineage bias, and myeloid differentiation in Mll partial tandem duplication (Mll-PTD) hematopoietic stem/progenitor cells. Blood\| PubMed ID: 22740449	2012
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 22753494	2012
RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 22753902	2012
Genome-wide methylation profiling in decitabine-treated patients with acute myeloid leukemia. Blood\| PubMed ID: 22786882	2012
Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. The Journal of clinical investigation\| PubMed ID: 22820288	2012
Quantitative assessment of motor abnormalities in untreated patients with major depressive disorder. Journal of affective disorders\| PubMed ID: 22985485	2013
A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma. Blood\| PubMed ID: 23033266	2012
Nonadherence to the isochrony principle in forged signatures. Forensic science international\| PubMed ID: 23084659	2012
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia. Blood\| PubMed ID: 23100311	2013
Aberrant Overexpression of IL-15 Initiates Large Granular Lymphocyte Leukemia through Chromosomal Instability and DNA Hypermethylation. Cancer cell\| PubMed ID: 23153537	2012
inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations. Blood\| PubMed ID: 23160462	2013
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nature medicine\| PubMed ID: 23178246	2012
Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood\| PubMed ID: 23223432	2013
Inhibition of the receptor tyrosine kinase Axl impedes activation of the FLT3 internal tandem duplication in human acute myeloid leukemia: implications for Axl as a potential therapeutic tar... Blood\| PubMed ID: 23321254	2013
Identification of a 24-gene prognostic signature that improves the European LeukemiaNet risk classification of acute myeloid leukemia: an international collaborative study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 23382473	2013
Comparative assessment of clinically utilized CD20-directed antibodies in chronic lymphocytic leukemia cells reveals divergent NK cell, monocyte, and macrophage properties. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 23418626	2013
Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells. Blood\| PubMed ID: 23422749	2013
Targeted delivery of microRNA-29b by transferrin-conjugated anionic lipopolyplex nanoparticles: a novel therapeutic strategy in acute myeloid leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 23493348	2013
Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. Journal of hematology & oncology\| PubMed ID: 23497456	2013
MicroRNAs activate natural killer cells through Toll-like receptor signaling. Blood\| PubMed ID: 23580661	2013
Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 23650424	2013
Axl/Gas6 pathway positively regulates FLT3 activation in human natural killer cell development. European journal of immunology\| PubMed ID: 23722894	2013
Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy. Oncoimmunology\| PubMed ID: 23734319	2013
In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline. Haematologica\| PubMed ID: 23753029	2013
Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes. Blood\| PubMed ID: 23886836	2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies. Blood\| PubMed ID: 23926298	2013
Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, dou... Schizophrenia research\| PubMed ID: 23938173	2013
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias. Blood\| PubMed ID: 23970380	2013
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. The Journal of clinical investigation\| PubMed ID: 23999433	2013
Location and cellular stages of natural killer cell development. Trends in immunology\| PubMed ID: 24055329	2013
Eradicating acute myeloid leukemia in a MllPTD/wt:Flt3ITD/wt murine model: a path to novel therapeutic approaches for human disease. Blood\| PubMed ID: 24085765	2013